Literature DB >> 15791919

Epilepsy, electroencephalographic abnormalities, and regression in children with autism.

Roberto Canitano1, Anna Luchetti, Michele Zappella.   

Abstract

The association of epilepsy and autism is recognized, and it has been reported at a percentage that varies between 8 and 42%, depending on age and diagnostic criteria. One third of autistic children undergo a regression of language and behavior between 2 and 3 years, and epileptiform abnormalities and epilepsy can be concomitant in an undetermined percentage of them. The aim of this study was to investigate the prevalence of epilepsy and paroxysmal abnormalities in a group of children with autism and to determine the percentage of regression course in this group. Forty-six patients with autism (mean age 7.8 +/- 2.7 years; 34 boys and 12 girls) were consecutively examined, and clinical evaluation, assessment, and electroencephalographic (EEG) recordings were performed in all of them. Thirty-five percent showed paroxysmal abnormalities and epilepsy, 22% had only paroxysmal abnormalities without seizures, and 13% of the children suffered from epilepsy. Sixty-five percent had a normal EEG. No difference in regression rate was observed between patients with paroxysmal abnormalities and epilepsy and those with a normal EEG and without seizures. In the study group, the prevalence of epilepsy was in the low range of individuals with autism, and different types of epilepsy were observed. Autism with regression was not influenced by paroxysmal abnormalities and epilepsy.

Entities:  

Mesh:

Year:  2005        PMID: 15791919     DOI: 10.1177/08830738050200010401

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  25 in total

1.  Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.

Authors:  Elizabeth Hammock; Jeremy Veenstra-VanderWeele; Zhongyu Yan; Travis M Kerr; Marianna Morris; George M Anderson; C Sue Carter; Edwin H Cook; Suma Jacob
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-05-26       Impact factor: 8.829

2.  Physician Perspectives on Providing Primary Medical Care to Adults with Autism Spectrum Disorders (ASD).

Authors:  Marji Erickson Warfield; Morgan K Crossman; Jennifer Delahaye; Emma Der Weerd; Karen A Kuhlthau
Journal:  J Autism Dev Disord       Date:  2015-07

Review 3.  Epilepsy in autism spectrum disorders.

Authors:  Roberto Canitano
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-24       Impact factor: 4.785

4.  Exploring the relationship between autism spectrum disorder and epilepsy using latent class cluster analysis.

Authors:  Michael L Cuccaro; Roberto F Tuchman; Kara L Hamilton; Harry H Wright; Ruth K Abramson; Jonathan L Haines; John R Gilbert; Margaret Pericak-Vance
Journal:  J Autism Dev Disord       Date:  2012-08

Review 5.  Epilepsy and Autism.

Authors:  Ashura W Buckley; Gregory L Holmes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

6.  A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging.

Authors:  Kamal Abulebda; Ryan Louer; Riad Lutfi; Sheikh Sohail Ahmed
Journal:  J Autism Dev Disord       Date:  2018-09

Review 7.  Developmental regression in autism spectrum disorder.

Authors:  Nouf Backer Al Backer
Journal:  Sudan J Paediatr       Date:  2015

Review 8.  The role of epilepsy and epileptiform EEGs in autism spectrum disorders.

Authors:  Sarah J Spence; Mark T Schneider
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

9.  Clinical characteristics associated with language regression for children with autism spectrum disorders.

Authors:  Lauren A Jones; Jonathan M Campbell
Journal:  J Autism Dev Disord       Date:  2009-07-25

Review 10.  What's new in autism?

Authors:  Jean G Steyaert; Wouter De la Marche
Journal:  Eur J Pediatr       Date:  2008-07-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.